Marco Bortolomasi
Overview
Explore the profile of Marco Bortolomasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galbiati C, Dattilo V, Bortolomasi M, Vitali E, Abate M, Menesello V, et al.
J ECT
. 2025 Jan;
PMID: 39792703
Objectives: Electroconvulsive therapy (ECT) is one of the most effective treatments for treatment-resistant depression (TRD), even though the molecular mechanisms underlying its efficacy remain largely unclear. This study aimed, for...
2.
Squassina A, Pisanu C, Menesello V, Meloni A, Congiu D, Manchia M, et al.
J ECT
. 2024 Aug;
PMID: 39178054
Objectives: In this study, we investigated if changes in leukocyte telomere length (LTL) and mitochondrial DNA copy number (mtDNA-cn), 2 markers of cellular aging, are associated with treatment-resistant depression (TRD)...
3.
Carvalho Silva R, Martini P, Hohoff C, Mattevi S, Bortolomasi M, Abate M, et al.
Clin Epigenetics
. 2024 Jul;
16(1):93.
PMID: 39020437
Background: Electroconvulsive therapy (ECT) benefits patients with treatment-resistant depression (TRD), but the underlying biological processes are unclear. We conducted an epigenome-wide association study in 32 TRD patients undergoing ECT to...
4.
Carvalho Silva R, Martini P, Hohoff C, Mattevi S, Bortolomasi M, Menesello V, et al.
Eur J Psychotraumatol
. 2024 Feb;
15(1):2314913.
PMID: 38362742
: Stressful events increase the risk for treatment-resistant depression (TRD), and trauma-focused psychotherapy can be useful for TRD patients exposed to early life stress (ELS). Epigenetic processes are known to...
5.
Carvalho Silva R, Pisanu C, Maffioletti E, Menesello V, Bortolomasi M, Gennarelli M, et al.
Eur Neuropsychopharmacol
. 2023 Aug;
76:89-107.
PMID: 37595325
Major depressive disorder (MDD) presents different clinical features in women and men, with women being more affected and responding differently to antidepressant treatment. Specific molecular mechanisms underlying these differences are...
6.
DUrso G, Dini M, Bonato M, Gallucci S, Parazzini M, Maiorana N, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884985
Depressive disorders are one of the leading causes of disability worldwide. Transcranial direct current stimulation (tDCS) is a safe, simple, non-invasive brain stimulation technique showing considerable effectiveness in improving depressive...
7.
Dattilo V, Ulivi S, Minelli A, Bianca M, Giacopuzzi E, Bortolomasi M, et al.
World J Biol Psychiatry
. 2022 May;
24(2):135-148.
PMID: 35615967
Objectives: Major depressive disorder (MDD) is a psychiatric disorder with pathogenesis influenced by both genetic and environmental factors. To date, the molecular-level understanding of its aetiology remains unclear. Thus, we...
8.
Minelli A, Carvalho Silva R, Barlati S, Vezzoli M, Carletto S, Isabello C, et al.
Brain Sci
. 2022 Mar;
12(3).
PMID: 35326364
Despite extensive research on COVID-19's impact on healthcare workers, few studies have targeted mental health workers (MHWs) and none have investigated previous traumatic events. We investigated psychological distress in MHWs...
9.
Maffioletti E, Bocchio-Chiavetto L, Perusi G, Carvalho Silva R, Sacco C, Bazzanella R, et al.
Eur J Psychotraumatol
. 2022 Jan;
12(1):1987655.
PMID: 35070159
Background: About 30% of major depressive disorder (MDD) patients are classified as resistant to treatment (treatment-resistant depression, TRD). Among the factors associated with unfavourable treatment outcomes, stressful life events play...
10.
Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, et al.
Eur Neuropsychopharmacol
. 2021 Nov;
55:86-95.
PMID: 34844152
About two-thirds of patients with major depressive disorder (MDD) fail to achieve symptom remission after the initial antidepressant treatment. Despite a role of genetic factors was proven, the specific underpinnings...